8.3.1. long-term (> twelve months) quality life outcomes men localised disease. 8.3.1.1. men undergoing local treatments updated results protect trial treatment-received analyses revealed different impacts treatments six1398042195years. men remaining experienced gradual declines sexual urinary function age increases ed 35% baseline 53% six1398042195years nocturia 20% 38%. radical treatment impacts immediate continued six1398042195years. rp, 95% reported ed persisting 85% six1398042195years, ebrt 69% 74%, respectively (p1398042195<13980421950.001 compared am). rp, 36% reported urinary leakage requiring least one1398042195pad/day, persisting 20% six1398042195years, compared change men receiving ebrt (p1398042195<13980421950.001). worse bowel function bother bloody stools 6% six1398042195years faecal incontinence 10%, experienced men ebrt rp (p1398042195<13980421950.001) lesser effects bt. treatment affected mental physical qol. another paper twelve years outcome trial , seen generic quality-of-life scores similar randomised groups seven twelve years, urinary leakage requiring pads occurred 18-24% patients prostatectomy group seven twelve years, compared 9-11% group 3-8% radiotherapy group. erections sufficient intercourse reported 18% seven years prostatectomy group, compared 30% 27% radiotherapy groups; converged low levels potency year twelve. nocturia (voiding least twice per night) occurred 34% prostatectomy group compared 48% radiotherapy group 47% group twelve years. faecal leakage affected 12% radiotherapy group compared 6% groups year twelve. group experienced gradual age-related declines sexual urinary function, avoiding radical treatment effects unless changed management. observational studies [668,1243,1354,1445-1448] also report findings regarding rp rt. prostate cancer outcomes study (pcos) studied cohort 1,655 men, 1,164 undergone rp 491 rt . study reported five years follow-up, men underwent rp higher prevalence urinary incontinence ed, men treated rt higher prevalence bowel dysfunction. however, despite differences detected five years, significant differences adjusted odds urinary incontinence, bowel dysfunction ed rp rt fifteen years. investigators reported although ebrt associated negative effect bowel function, difference bowel domain score threshold clinical significance twelve months treatment . 81% patients ebrt arm study received imrt, data suggest risk side effects reduced imrt compared older 3d-crt techniques. supported five-year prospective, population-based cohort study proms compared men favourable- unfavourable-risk localised disease . 1,386 men favourable risk, comparison nerve-sparing prostatectomy, ebrt ldr bt demonstrates surgery associated worse urinary incontinence five years sexual dysfunction three years compared as. external beam rt associated changes clinically different as, ldr bt associated worse irritative urinary-, bowel- sexual symptoms one year. 619 men high-risk localised disease, comparison non-nerve sparing rp ebrt adt demonstrates surgery associated worse urinary incontinence sexual function five years. sr demonstrates risk post-radiotherapy ed reduced median 25% two years utilisation imrt similar noted ldr bt . prospective studies reported specific long-term urinary functional outcomes rp rt even studies comparative two treatment modalities. considering incontinence ed rp prospective randomised pivot trial, comparing rp observation, reported 40% men wore pads, 20% wore > one pad/day, increased rate ed rp group compared observation 70% approximately 87%, median follow-up 12.7 years . corresponding figures prospective non-randomised lappro-trial, comparing open- robot-assisted rp, 27–29% patients reporting urinary incontinence degree eight years 66–70% reporting ed . data urinary, sexual bowel function rt reported hypo-rt-pc-trial, prospective randomised non-inferiority trial comparing ultra-hfx conventional fractionation rt. trial 52–55% patients reported urinary problems (rtog toxicity grade ≥ 1) five years, 4.2–4.7% reported rtog grade ≥ 3 urinary morbidity 7–8% reported moderate-to-severe incontinence six years. bowel toxicity level (rtog toxicity grade ≥ 1) reported 53–54% patients five years, 1.5–1.9% reported rtog grade ≥ 3 bowel morbidity, 66–71% reported little erection without aids six years follow-up . 8.3.1.2. guidelines quality life men undergoing local treatments recommendationsstrength ratingadvise eligible patients active surveillance global quality life equivalent five years compared radical prostatectomy external beam radiotherapy (rt).strongdiscuss negative impact surgery urinary sexual function, well negative impact rt bowel function patients.strongadvise patients treated brachytherapy negative impact irritative urinary symptomatology one year five years.weak